Binimetinib Encorafenib Pembrolizumab +/- Stereotactic Radiosurgery in BRAFV600 Melanoma With Brain Metastasis

Clinical trial NCT04074096 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04074096
Sponsor: UNICANCER
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Malignant Melanoma BRAF V600 Mutation Brain Metastases

Start date: 2022-09-05
Primary completion: 2026-05-07
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.